Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Lilly Eli & Co
Relationship:   10% Owner
City:   Indianapolis
State:   IN
   
Insider Summary:
  
   
Companies Owned :   11    
Direct Shares   17,228,056    

Indirect Shares

   2,568,543      
Direct Value   $1,528,892,139    

Indirect Value

   $1,542,924      
Total Shares   19,796,599      
Total Value   $1,530,435,063      


Icagen Inc $0 Ionis Pharmaceuticals Inc $107,525,000 United Therapeutics Corp $1,339,840,665 Zosano Pharma Corp $163,909 Zymeworks Inc $25,392,148 Avidity Biosciences, Inc. $55,970,417 Sigilon Therapeutics, Inc. $0 Prevail Therapeutics Inc. $0 Akouos, Inc. $0 Icagen Inc $0 Ionis Pharmaceuticals Inc $107,525,000 United Therapeutics Corp $1,339,840,665 Zosano Pharma Corp $163,909 Zymeworks Inc $25,392,148 Avidity Biosciences, Inc. $55,970,417 Sigilon Therapeutics, Inc. $0 Prevail Therapeutics Inc. $0 Akouos, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Icagen Inc ICGN 10% Owner 2005-02-08 300,340 2005-02-08 0    Premium*  
            Ionis Pharmaceuticals Inc IONS 10% Owner 2005-08-05 2,500,000 0    Premium*  
            United Therapeutics Corp UTHR 10% Owner 2011-07-06 5,251,394 0    Premium*  
            Zosano Pharma Corp ZSAN 10% Owner 2015-01-30 1,363,636 0    Premium*  
            Aeglea Biotherapeutics, Inc. AGLE 10% Owner 2016-04-12 0 2016-04-12 2,568,543    Premium*  
            Zymeworks Inc ZYME 10% Owner 2019-01-31 2,898,647 2018-08-02 0    Premium*  
            Elanco Animal Health Inc ELAN 10% Owner 2019-03-11 0 2019-03-11 0    Premium*  
            Avidity Biosciences, Inc. RNA 2020-06-16 2,169,396 2020-06-16 0    Premium*  
            Sigilon Therapeutics, Inc. SGTX 10% Owner 2020-12-08 2,744,443 2020-12-08 0    Premium*  
            Prevail Therapeutics Inc. PRVL 10% Owner 2021-01-22 100 2021-01-22 0    Premium*  
            Akouos, Inc. AKUS 10% Owner 2022-11-30 100 2022-11-30 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AKUS Akouos, Inc. 10% Owner   –       –       •   2022-11-30 4 B $12.50 $374,908,350 D/D 29,992,668 100 2.45 -
PRVL Prevail Therapeutics Inc. 10% Owner   –       –       •   2021-01-22 4 B $22.50 $771,407,753 D/D 34,284,789 100 2.45 -
SGTX Sigilon Therapeutics, Inc... 10% Owner   –       –       •   2020-12-08 4 B $18.00 $5,400,000 D/D 300,000 2,744,443 2.45 -
SGTX Sigilon Therapeutics, Inc... 10% Owner   –       –       •   2020-12-08 4 A $0.00 $0 D/D 2,444,443 2,444,443 0 -
RNA Avidity Biosciences, Inc.   •       •       •   2020-06-16 4 A $0.00 $0 D/D 2,169,396 2,169,396 0 -
ELAN Elanco Animal Health Inc 10% Owner   –       –       •   2019-03-11 4 D $0.00 $0 D/D (293,290,000) 0 0 -
ZYME Zymeworks Inc 10% Owner   –       –       •   2019-01-31 4 S $16.00 $4,000,000 D/D (250,000) 2,898,647 0 -
ZYME Zymeworks Inc 10% Owner   –       –       •   2018-11-06 4 S $14.00 $9,800,000 D/D (700,000) 3,148,647 0 -
ZYME Zymeworks Inc 10% Owner   –       –       •   2018-09-24 4 S $16.36 $33,162 D/D (2,027) 3,848,647 0 -
ZYME Zymeworks Inc 10% Owner   –       –       •   2018-09-18 4 S $14.56 $100,027 D/D (6,870) 3,850,674 0 -
ZYME Zymeworks Inc 10% Owner   –       –       •   2018-09-17 4 S $14.58 $100,092 D/D (6,865) 3,857,544 0 -
ZYME Zymeworks Inc 10% Owner   –       –       •   2018-09-14 4 S $14.58 $131,351 D/D (9,009) 3,864,409 0 -
ZYME Zymeworks Inc 10% Owner   –       –       •   2018-09-13 4 S $14.32 $299,288 D/D (20,900) 3,873,418 0 -
ZYME Zymeworks Inc 10% Owner   –       –       •   2018-09-12 4 S $14.83 $149,175 D/D (10,059) 3,894,318 0 -
ZYME Zymeworks Inc 10% Owner   –       –       •   2018-09-11 4 S $14.87 $167,689 D/D (11,277) 3,904,377 0 -
ZYME Zymeworks Inc 10% Owner   –       –       •   2018-09-10 4 S $14.44 $64,980 D/D (4,500) 3,915,654 0 -
ZYME Zymeworks Inc 10% Owner   –       –       •   2018-08-31 4 S $14.26 $9,982 D/D (700) 3,920,154 0 -
ZYME Zymeworks Inc 10% Owner   –       –       •   2018-08-30 4 S $14.35 $49,364 D/D (3,440) 3,920,854 0 -
ZYME Zymeworks Inc 10% Owner   –       –       •   2018-08-29 4 S $14.26 $32,969 D/D (2,312) 3,924,294 0 -
ZYME Zymeworks Inc 10% Owner   –       –       •   2018-08-14 4 S $14.28 $42,840 D/D (3,000) 3,926,606 0 -
ZYME Zymeworks Inc 10% Owner   –       –       •   2018-08-13 4 S $14.33 $64,929 D/D (4,531) 3,929,606 0 -
ZYME Zymeworks Inc 10% Owner   –       –       •   2018-08-10 4 S $14.28 $27,103 D/D (1,898) 3,934,137 0 -
ZYME Zymeworks Inc 10% Owner   –       –       •   2018-08-03 4 S $13.55 $22,358 D/D (1,650) 3,936,035 0 -
ZYME Zymeworks Inc 10% Owner   –       –       •   2018-08-02 4 S $13.31 $258,214 D/D (19,400) 3,937,685 0 -
AGLE Aeglea Biotherapeutics, I... 10% Owner   –       –       •   2016-04-12 4 B $10.00 $5,000,000 I/I 500,000 2,568,543 1.5 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us